Summit Therapeutics, Inc. · 7 hours ago
Director, Patient Engagement & Advocacy
Maximize your interview chances
BiotechnologyHealth Care
H1B Sponsor Likely
Insider Connection @Summit Therapeutics, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Lead, plan, and execute the pre-, peri-, and post-launch patient engagement and advocacy strategy
Assess patient engagement needs develop, and execute programs internally or through external vendors, to address those needs
Collaborate cross-functionally with internal stakeholders, including clinical development, clinical operations, medical affairs, market access, and commercial, to integrate relevant patient engagement measures into clinical studies and commercialization plans
Engage effectively with patient groups, clinical experts, and payers to evaluate and address knowledge gaps regarding ivonescimab and its potential uses, understand the burden of diseases potentially treated by ivonescimab, and identify opportunities for collaboration on patient education and involvement in ivonescimab clinical studies.
Lead the development of data dissemination plans and communicate complex clinical scientific content, including clinical trials result, in a manner suitable for patients
Stay updated with advancements in patient engagement methodologies and best practices, particularly in solid tumors related oncology
All other duties as assigned.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s degree in a relevant field (e.g., public health, social work, nursing, pharmacy); Advanced degree preferred.
7+ years of relevant experience in patient advocacy, engagement, or related roles within the pharmaceutical or healthcare industry
Proven track record of developing and implementing successful patient engagement strategies
In-depth understanding of the healthcare and pharmaceutical landscape, including regulatory requirements
Strong leadership and project management skills
Excellent communication and interpersonal abilities
Ability to work collaboratively across diverse teams and manage multiple stakeholders
Domestic and international travel required, expected to be 10-20% of the time and as needed
Proficient user of the standard MS Office suite (e.g., Word, Excel); experience with electronic document management systems and document review tools is desirable.
Attention to detail, accuracy, and confidentiality
Clear and concise oral and written communication skills
Excellent organizational skills
Critical thinking and high problem-solving abilities
Self-motivated, ability to work independently and achieve success with little oversight or guidance
Must be able to effectively multi-task and manage time-sensitive and highly confidential documents
Communicate effectively and articulate complex ideas in an easily understandable way
Prioritize conflicting demands
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
H1B Sponsorship
Summit Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.29BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
2023-01-30Post Ipo Equity· $500M
Recent News
2024-11-27
Company data provided by crunchbase